Datasheet 2: Vitiligo - An Autoimmune Skin Disease and Its Immunomodulatory Therapeutic Intervention
December 2021
in “
OPAL (Open@LaTrobe) (La Trobe University)
”
Studysummary This review discusses recent advancements in targeted therapies for vitiligo, highlighting the therapeutic potential of JAK inhibitors and mesenchymal stem cell-derived extracellular vesicles, and reports no new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on figshare.com →